Abstract
The marijuana plant contains in excess of 400 chemical entities, of which 60 or more are cannabinoids (1). Delta-9-tetrahydrocannabinol (THC) is the major psychoactive cannabinoid in marijuana and has been shown to induce immunosuppressive effects both in vivo and in vitro. The drug inhibits lymphocyte responsiveness to mitogens and particulate antigens (2), decreases T-cell rosette formation (3,4), suppresses leukocyte migration (5), and alters macrophage morphology, function, motility, and protein expression (6–8).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
C. E. Turner, Marijuana and cannabis: research. Why the conflict, in: “Marihuana ’84,” D. J. Harvey ed., IRL Press, Oxford (1985).
G. E. Nahas, N. Sucia-Foca, J. P. Armand, and A. Morishima, Inhibition of cellular mediated immunity in marihuana smokers, Science 183:419 (1974).
G. Gupta, M. Grieco, and P. Cushman, Impairment of rosette forming T-lymphocytes in chronic marijuana users, New Engl. J. Med. 291:874 (1974).
P. Cushman and R. Khurana, Marijuana and T-lymphocyte rosettes, Clin. Pharmacol. Ther. 19:310 (1976).
L. Schwartzfarb, N. Needle and M. Chavez-Chase, Dose related inhibition of leukocyte migration by marijuana and Delta-9-tetrahydrocannabinol, J. Clin. Pharmacol. 14:35 (1974).
M. Lopez-Cepero, M. Friedman, T. Klein, and H. Friedman, Tetrahydrocannabinol-induced suppression of macrophage spreading and phagocytic activity in vitro, J. Leuk. Biol. 39:679 (1986).
G. A. Cabral and E. M. Mishkin, Delta-9-tetrahydrocannabinol inhibits macrophage protein expression in response to bacterial immunomodulators, J. Tox. Environ. Health ,26:175 (1989).
G. A. Cabral, A. L. Stinnett, J. Bailey, S. F. Ali, M. G. Paule, A. C. Scallet, and W. Slikker Jr, Chronic Marijuana Smoke Alters Alveolar Macrophage Morphology and Protein Expression, Pharm. Biochem. Behav. 40:643 (1991).
E. M. Mishkin and G. A. Cabral, Delta-9-tetrahydrocannabinol decreases host resistance to herpes simplex virus type 2 vaginal infection in the B6C3F1 mouse, J. Gen. Virol. 66:2639 (1985).
G. A. Cabral, E. M. Mishkin, F. Marciano-Cabral, P. Coleman, L. Harris, and A. E. Munson, Effect of delta-9-tetrahydrocannabinol on herpes simplex virus type 2 vaginal infection in the guinea pig, Proc. Soc. Exp. Biol. Med. 182:181 (1986).
G. A. Cabral, J. C. Lockmuller, and E. M. Mishkin, Delta-9-tetrahydrocannabinol decreases alpha/beta interferon response to herpes simplex virus type 2 in the B6C3F1 mouse, Proc. Soc. Exp. Biol. Med 181:305 (1987).
B. E. Juel-Jensen, Cannabis and recurrent herpes simplex, Br. Med. J. IV:296 (1972).
M. P. Holsapple, E. M. Mishkin, A. E. Munson, and G. A. Cabral, In vivo and in vitro effects of Delta-9-tetrahydrocannabinol on immune responsiveness and vaginal resistance to herpes simplex virus type II (HSV2) infection by B6C3F1 mice, in: “Marihuana ’84,” D. J. Harvey ed., IRL Press, Oxford (1985).
S. Pross, T. Klein, C. Newton, and H. Friedman, Differential effects of marijuana components on proliferation of spleen, lymph node and thymus cells in vitro, Intl. J. Immunopharmac. 9(3):363 (1987).
Y. Kawakami, T. W. Klein, C. Newton, J. Y. Djeu, G. Dennert, S. Specter, and H. Friedman, Suppression by cannabinoids of a cloned cell line with natural killer cell activity, Proc. Soc. Exp. Biol. Med. 187(3):355 (1988).
S. Specter, G. Lancz, and J. Hazelden, Marijuana and Immunity: Tetrahydrocannabinol mediated inhibition of lymphocyte blastogenesis, Int. J. Immunopharmac. 12(3):261 (1990).
T. W. Klein and H. Friedman, Modulation of murine immune cell function by marijuana components, in: “CRC Drugs of Abuse and Immune Function,” R.R. Watson ed., CRC Press, Boca Raton (1990).
C. R. Plata-Salaman, Immunoregulators in the nervous system, Neurosci. Biobehav. Rev. 15:182 (1991).
B. McEwen, Influences of hormones and neuroactive substances on immune function, in: “The Neuro-Immune-Endocrine-Connection,” C.W. Cotman ed., Raven Press, New York (1987).
B. B. Mishell, S. M. Shiigi, C. Henry, E. L. Chan, J. North, R. Gallily, M. Slomich, K. Miller, J. Marbrook, D. Parks, and A. H. Good, Preparation of mouse cell suspensions, in: “Selected Methods in Cellular Immunology,” B. B. Mishell and S. M. Shiigi eds., WH Freeman and Company, San Francisco (1980).
B. B. Mishell, S. M. Shiigi, C. Henry, E. L. Chan, J. North, R. Gallily, M. Slomich, K. Miller, J. Marbrook, D. Parks, and A. H. Good, Determination of viability by trypan blue exclusion, in: “Selected Methods in Cellular Immunology,” B. B. Mishell and S. M. Shiigi eds., WH Freeman and Company, San Francisco (1980).
K. O. Smith, Relationship between the envelope and the infectivity of herpes simplex virus, Proc. Soc. Exp. Biol. Med. 115:814 (1964).
F. Rapp, Variants of herpes simplex virus: isolation, characterization and factors influencing plaque formation, J. Bacteriol. 86:985 (1963).
D. L. Beller, Collection of Macrophages from the spleen, thymus, and bone marrow, in: “Manual of Macrophage Methodology,” H. B. Herscowitz, T. H. Holden, J. A. Bellanti, and A. Ghaffar, eds., Marcel Dekker, Inc., New York (1981).
J. M. Chirgwin, A. E. Przybyla, R. Y. MacDonald, and W. J. Rutter, Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease, Biochem. 18:5284 (1977).
L. A. Matsuda, S. J. Lolait, M. J. Brownstein, A. C. Young, and T. I. Bonner, Structure of a cannabinoid receptor and functional expression of the cloned cDNA, Nature 346:561 (1990).
T. W. Klein, C. A. Newton, R. Weden, and H. Friedman, The effect of delta-9-tetrahydrocannabinol and 11-hydroxy-delta-9-tetrahydrocannabinol on T-lymphocyte and B-lymphocyte mitogen responses, J. Immunopharm. 7(4):451 (1985).
P. S. Morahan, S. S. Morse, and M. B. McGeorge, Macrophage extrinsic antiviral activity during herpes simplex virus infection, J. Gen. Virol 46:291 (1980).
P. S. Morahan, P. C. Klykken, S. H. Smith, L. S. Harris, and A. E. Munson, Effects of cannabinoids on host resistance to Listeria monocytogenes and herpes simplex virus, Infect. Immun. 23:670 (1979).
R. V. Blanden, T cell response to viral and bacterial infection, Transplant. Rev. 19:56 (1974).
K. L. Yap and G. L. Ada, The recovery of mice from influenza A virus infection: adoptive transfer of immunity with immune T lymphocytes, Scand. J. Immunol. 7:389 (1978).
H. W. Kreth, V. T. Meulen, and G. Eckert, Demonstration of HLA restricted killer cells in patients with acute measles, Med. Micobiol. Immunol. (Berl) 165:203 (1979).
L. Y. Lin and B. A. Askonas, Cross-reactivity for different type A influenza viruses of a cloned T killer cell line, Nature 288:164 (1980).
B. T. Rouse and M. Lawman, Induction of cytotoxic T lymphocytes against herpes simplex virus type 1: role of accessory cells and amplifying factor, J. Immunol. 124:2341 (1980).
M. J. Lawman, B. T. Rouse, R. J. Courtney, and R. D. Walker, Cell-mediated immunity against herpes simplex induction of cytotoxic T lymphocytes, Infect. Immun. 27:133 (1980).
E. Martz, Mechanism of specific tumor cell lysis by alloimmune T lymphocytes: resolution and characterization of discrete steps in the cellular interaction, Contemp. Topics Immunobiol. 7:301 (1977).
G. A. Cabral and R. Vasquez, Effects of marihuana on macrophage function, in: “Drugs of Abuse, Immunity, and Immunodeficiency,” H. Friedman, S. Specter, T. Klein, eds., Plenum Press, New York (1991).
M. K. Poddar, G. Mittra, and J. J. Ghosh, Delta-9-tetrahydrocannabinol-induced changes in brain ribosomes, Toxicol. Appl. Pharmacol. 46:737 (1978).
W. A. Meyers and R. G. Heath, Cannabis sativa: ultrastructural changes in organelles and neurons in brain septal region of monkeys, J. Neurosci. Res. 4:9 (1979).
G. A. Cabral, P. J. McNerney, and E. M. Mishkin, Interaction of delta-9-tetrahydrocannabinol with rat B103 neuroblastoma cells, Archiv. Toxicol. 60:438 (1987).
D. R. Wing, J. T. Leuschner, G. A. Brent, D. J. Harvey, and W. D. Paton, Quantification of in vivo membrane associated delta-1-tetrahydrocannabinol and its effect on membrane fluidity, in: “Proc. Of 9th Internatl. Cong. of Pharmacol. 3rd Satellite Symp. on Cannabis” D. J. Harvey ed., IRL Press, Oxford (1985).
E. Leopardi, D. S. Friend, and W. Rosenau, Target cell lysis: ultrastructural and cytoskeletal alterations, J. Immunol. 133:3429 (1984).
G. A. Cabral and R. Vasquez, Marijuana decreases macrophage antiviral and antitumor activities, Adv. Biosc. 80:93 (1991).
C. M. Gerard, C. Mollereau, G. Vassart, and M. Parmentier, Molecular cloning of a human cannabinoid receptor which is also expressed in testis, Biochem. J. 279(1):129 (1991).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media New York
About this chapter
Cite this chapter
Cabral, G.A., Pettit, D.A.D., Fischer-Stenger, K. (1993). Marijuana and Host Resistance to Herpesvirus Infection. In: Friedman, H., Klein, T.W., Specter, S. (eds) Drugs of Abuse, Immunity, and AIDS. Advances in Experimental Medicine and Biology, vol 335. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2980-4_14
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2980-4_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6297-5
Online ISBN: 978-1-4615-2980-4
eBook Packages: Springer Book Archive